|
271 Companies |
|
374 Products |
|
374 Products |
|
160 Mechanisms of Action |
|
34 Trials |
|
5514 News |
|
| «12...96979899100101102103104105106...110111» |
- polyvalent vaccine-KLH conjugate / MabVax, Avastin (bevacizumab) / Roche
Enrollment closed, Combination therapy, IO biomarker: Polyvalent Vaccine-KLH Conjugate + Opt-821 Given in Combination With Bevacizumab (clinicaltrials.gov) - Jul 24, 2012
P=N/A, N=22, Active, not recruiting, Sponsor: Memorial Sloan-Kettering Cancer Center
Recruiting --> Active, not recruiting
- Leukine (sargramostim) / Partner Therap
Trial termination: S0114 Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian Cancer (clinicaltrials.gov) - Jul 19, 2012
P1, N=14, Terminated, Sponsor: Southwest Oncology Group
Recruiting --> Active, not recruiting Active, not recruiting --> Terminated; lack of accrual
- Leukine (sargramostim) / Partner Therap
Enrollment change: S0114 Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian Cancer (clinicaltrials.gov) - Jul 19, 2012
P1, N=14, Terminated, Sponsor: Southwest Oncology Group
Active, not recruiting --> Terminated; lack of accrual N=24 --> 14
- Preclinical, Trial termination: Polycystic Ovary Syndrome (PCOS) and In Vitro Fertilization (IVF): A Comparison Between Standard Long Protocol Versus an Antagonist Protocol Starting on Day 1 (clinicaltrials.gov) - Jul 18, 2012
P=N/A, N=172, Terminated, Sponsor: Institut Universitari Dexeus
N=24 --> 14 Recruiting --> Terminated
- Oncaspar liquid (pegaspargase) / Servier
Trial completion: Phase II Study of Clinical Activity of Pegaspargase in Women With Relapsed or Refractory Epithelial Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer (clinicaltrials.gov) - Jul 18, 2012
P2, N=4, Completed, Sponsor: National Cancer Institute (NCI)
Recruiting --> Terminated Active, not recruiting --> Completed
- Clinical: Plasma Levels of GDF-9 and GDF-15 in Patients With Polycystic Ovary Syndrome. (clinicaltrials.gov) - Jul 17, 2012
P=N/A, N=0, Active, not recruiting, Sponsor: Ankara Education and Research Hospital
- | Trial completion: Clinical Evaluation of the Surgisis Biodesign Vesico-Vaginal Fistula Plug (clinicaltrials.gov) - Jul 17, 2012
P=N/A, N=20, Completed, Sponsor: Cook
Active, not recruiting --> Completed Recruiting --> Completed
- | Votrient (pazopanib) / Novartis, BeiGene
New P2 trial: MITO-11: Weekly Paclitaxel With or Without Pazopanib in Platinum Resistant or Refractory Ovarian Cancer (clinicaltrials.gov) - Jul 17, 2012
P2, N=72, Active, not recruiting, Sponsor: National Cancer Institute, Naples
- Yondelis (trabectedin) / PharmaMar, J&J, Neulasta (pegfilgrastim) / Roche
Trial completion: Docetaxel, Trabectedin, and G-CSF or Pegfilgrastim in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer (clinicaltrials.gov) - Jul 17, 2012
P2, N=70, Completed, Sponsor: Gynecologic Oncology Group
Recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion, Metastases: Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix (clinicaltrials.gov) - Jul 17, 2012
P3, N=600, Completed, Sponsor: Gynecologic Oncology Group
Active, not recruiting --> Completed Active, not recruiting --> Completed
- dalantercept (ACE-041) / Merck (MSD)
New P2 trial: Dalantercept in Treating Patients With Recurrent or Persistent Endometrial Cancer (clinicaltrials.gov) - Jul 15, 2012
P2, N=28, Active, not recruiting, Sponsor: Gynecologic Oncology Group
- || New P3 trial: TOMOGYN: Phase III Study Comparing 3D Conformal Radiotherapy and Conformal Radiotherapy IMRT to Treat Endometrial Cancer (clinicaltrials.gov) - Jul 12, 2012
P3, N=60, Recruiting, Sponsor: Centre Oscar Lambret
- | New P2 trial: ANOXICOL: Study of a Predictor for Cervix Cancer (clinicaltrials.gov) - Jul 12, 2012
P2, N=60, Recruiting, Sponsor: Centre Oscar Lambret
- Trial termination: Yoga in Relieving Fatigue in Patients Undergoing Chemotherapy for Ovarian Cancer (clinicaltrials.gov) - Jul 11, 2012
P=N/A, N=2, Terminated, Sponsor: Comprehensive Cancer Center of Wake Forest University
Active, not recruiting --> Completed Completed --> Terminated; slow accrual
- Enrollment change: Yoga in Relieving Fatigue in Patients Undergoing Chemotherapy for Ovarian Cancer (clinicaltrials.gov) - Jul 11, 2012
P=N/A, N=2, Terminated, Sponsor: Comprehensive Cancer Center of Wake Forest University
Completed --> Terminated; slow accrual N=100 --> 2
- Trial completion, BRCA Biomarker: EXSAL: Search Allelic Imbalance of Expression of BRCA Genes in Hereditary Risk of Breast and/or Ovarian Cancer (clinicaltrials.gov) - Jul 11, 2012
P2, N=530, Completed, Sponsor: Centre Francois Baclesse
N=100 --> 2 Recruiting --> Completed
- carboplatin / Generic mfg., docetaxel / Generic mfg.
Biomarker, Preclinical, Retrospective data, Trial termination, Clinical Trial,Phase IV, Journal, Metastases: Docetaxel and Carboplatin in Treating Patients With Recurrent Stage IVB Squamous Cell Carcinoma (Cancer) of the Cervix (clinicaltrials.gov) - Jul 11, 2012
P1/2, N=15, Terminated, Sponsor: Comprehensive Cancer Center of Wake Forest University
Recruiting --> Completed Completed --> Terminated; slow accrual
- carboplatin / Generic mfg., docetaxel / Generic mfg.
Enrollment change, Metastases: Docetaxel and Carboplatin in Treating Patients With Recurrent Stage IVB Squamous Cell Carcinoma (Cancer) of the Cervix (clinicaltrials.gov) - Jul 11, 2012
P1/2, N=15, Terminated, Sponsor: Comprehensive Cancer Center of Wake Forest University
Completed --> Terminated; slow accrual N=64 --> 15
- ViraferonPeg (peginterferon-?-2b) / Merck (MSD)
New P1/2 trial: CHIP: Chemo-immunotherapy (Gemcitabine, Interferon-alpha 2b and p53 SLP) in Patients With Platinum-resistant Ovarian Cancer (clinicaltrials.gov) - Jul 11, 2012
P1/2, N=15, Completed, Sponsor: Leiden University Medical Center
- Cetrotide (cetrorelix) / EMD Serono
Trial completion: Ovarian Stimulation Using Recombinant Follicle-stimulating Hormone (FSH) and Gonadotrophin Releasing Hormone (GnRH) Agonist in Alternate Days (clinicaltrials.gov) - Jul 11, 2012
P=N/A, N=96, Completed, Sponsor: Fertility - Assisted Fertilization Center
N=64 --> 15 Recruiting --> Completed
- |||||||||| New P3 trial: Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding (clinicaltrials.gov) - Jul 10, 2012
P3, N=312, Recruiting, Sponsor: Bayer
- Trial completion: Endometrial Ablation With Non-hysteroscopic Methods (clinicaltrials.gov) - Jul 10, 2012
P4, N=66, Completed, Sponsor: Aristotle University Of Thessaloniki
Recruiting --> Completed Recruiting --> Completed
- etonogestrel/ethinylestradiol intravaginal ring / Generic mfg., desogestrel/ethinylestradiol / Generic mfg.
New P4 trial: NuvaRing Versus Marvelon in the Coordination of In Vitro Fertilization Cycles (clinicaltrials.gov) - Jul 10, 2012
P4, N=7, Terminated, Sponsor: OVO R & D
- ||| metformin / Generic mfg., clomifene citrate / Generic mfg.
New P3 trial: Clomifene Citrate Versus Metformin in First-line Treatment of Infertility in Patients With Polycystic Ovary Syndrome and a Resistance to Insulin (clinicaltrials.gov) - Jul 10, 2012
P3, N=401, Suspended, Sponsor: OVO R & D
- Trial completion: Follow-up Care After Treatment for Endometrial Cancer (clinicaltrials.gov) - Jul 10, 2012
P=N/A, N=20, Completed, Sponsor: Ottawa Hospital Research Institute
Recruiting --> Completed Recruiting --> Completed
- gemcitabine / Generic mfg., sorafenib / Generic mfg.
Trial completion, Combination therapy: Sorafenib Tosylate and Gemcitabine Hydrochloride in Treating Patients With Recurrent Epithelial Ovarian Cancer (clinicaltrials.gov) - Jul 10, 2012
P2, N=33, Completed, Sponsor: National Cancer Institute (NCI)
Recruiting --> Completed Active, not recruiting --> Completed
- | triptorelin / Generic mfg.
New P4 trial: Final Oocyte Maturation Via Administration of GnRH Agonists Followed By Luteal Support With hCG (clinicaltrials.gov) - Jul 9, 2012
P4, N=200, Not yet recruiting, Sponsor: HaEmek Medical Center, Israel
- Actemra IV (tocilizumab) / Roche, JW Pharma, ViraferonPeg (peginterferon-?-2b) / Merck (MSD)
New P1/2 trial: PITCH: Feasibility of the Combination of Chemotherapy (Carbo/Caelyx or Carbo/Doxorubicin) With Tocilizumab (mAb IL-6R) and Peg-Intron in Patients With Recurrent Ovarian Cancer (clinicaltrials.gov) - Jul 9, 2012
P1/2, N=21, Completed, Sponsor: Leiden University Medical Center
- | Trial completion: Pelvic Drains After Radical Hysterectomy in Treating Patients With Uterine, Cervical, or Vaginal Cancer (clinicaltrials.gov) - Jul 9, 2012
P3, N=214, Completed, Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion, Surgery: Radiation Therapy With or Without Chemotherapy After Surgery in Treating Patients With Stage IB or Stage IIA Cervical Cancer (clinicaltrials.gov) - Jul 9, 2012
P3, N=700, Completed, Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Neupogen (filgrastim) / Kyowa Kirin, Amgen
Trial completion, Surgery: SWOG-EORTC-62933: Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma (clinicaltrials.gov) - Jul 9, 2012
P3, N=340, Completed, Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial completion: TRAIL-CC: Trachelectomy, Radical Hysterectomy, and Intimate Life After Cervical Cancer Study (clinicaltrials.gov) - Jul 8, 2012
P=N/A, N=33, Completed, Sponsor: University of British Columbia
Active, not recruiting --> Completed Recruiting --> Completed
- Enrollment change: Pilot Study to Assess the Efficacy of Cognitive-behavioral Couple Therapy for Provoked Vestibulodynia (clinicaltrials.gov) - Jul 5, 2012
P=N/A, N=30, Active, not recruiting, Sponsor: Université de Montréal
Recruiting --> Completed N=10 --> 30
- | New P2 trial: LatinoSTYLE: Randomized Control Trial of Family-Based HIV Prevention for Latinos (clinicaltrials.gov) - Jul 5, 2012
P2, N=640, Recruiting, Sponsor: University of South Florida
- Trial withdrawal: Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant (clinicaltrials.gov) - Jul 4, 2012
P=N/A, N=0, Withdrawn, Sponsor: Roswell Park Cancer Institute
N=10 --> 30 Not yet recruiting --> Withdrawn
- Trial completion, Metastases: Disease Management Program or Usual Care in Patients With Stage III or Stage IV Lung Cancer, Pancreatic Cancer, Ovarian Cancer, or Colorectal Cancer, and Their Caregivers (clinicaltrials.gov) - Jul 4, 2012
P=N/A, N=605, Completed, Sponsor: Case Comprehensive Cancer Center
Not yet recruiting --> Withdrawn Active, not recruiting --> Completed
- Elonva (corifollitropin alfa) / Organon
New P4 trial: D2 Versus D4 Corifollitropin Alfa in GnRH Antagonists (clinicaltrials.gov) - Jul 2, 2012
P4, N=50, Recruiting, Sponsor: Universitair Ziekenhuis Brussel
- || aspirin / Generic mfg.
New P3 trial: The Effect of Low Dose Aspirin in Increasing the Chance of Pregnancy (clinicaltrials.gov) - Jul 2, 2012
P3, N=60, Completed, Sponsor: Royan Institute
- | bentamapimod (PGL5001) / Gedeon Richter
Enrollment open: PGL5001 Proof of Concept Study in Inflammatory Endometriosis (clinicaltrials.gov) - Jul 2, 2012
P2a, N=24, Recruiting, Sponsor: PregLem SA
Active, not recruiting --> Completed Active, not recruiting --> Recruiting
- Trial initiation date: WHC+ (Women's Health CoOp PLUS) (clinicaltrials.gov) - Jul 2, 2012
P1, N=600, Recruiting, Sponsor: RTI International
Active, not recruiting --> Recruiting Initiation date: Dec 2011 --> May 2012
- || ampicillin / Generic mfg., gentamicin sulfate / Generic mfg.
New P2/3 trial: Antibiotic Prophylaxis in Prelabor Rupture of Membranes at Term (clinicaltrials.gov) - Jul 2, 2012
P2/3, N=161, Completed, Sponsor: Hospital de Santa Maria, Portugal
- calcitriol (BPM 31543) / BPGbio
Enrollment open, Metastases: Compound 31543 (Calcitriol, USP) in Patients Receiving Taxane-based Chemotherapy Regimens for Advanced or Recurrent Disease (clinicaltrials.gov) - Jul 2, 2012
P1, N=18, Recruiting, Sponsor: Berg Pharma,LLC
Initiation date: Dec 2011 --> May 2012 Not yet recruiting --> Recruiting
- Enrollment open: WHC+ (Women's Health CoOp PLUS) (clinicaltrials.gov) - Jul 2, 2012
P1, N=600, Recruiting, Sponsor: RTI International
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- Trial completion: Single Versus Conventional Laparoscopy for Benign Adnexal Disease (clinicaltrials.gov) - Jun 28, 2012
P3, N=40, Completed, Sponsor: Sorlandet Hospital HF
Not yet recruiting --> Recruiting Recruiting --> Completed
- Avastin (bevacizumab) / Roche
Trial termination: Study of Revlimid With Doxil and Avastin for Patients With Platinum Resistant Ovarian Cancer (clinicaltrials.gov) - Jun 28, 2012
P1, N=1, Terminated, Sponsor: New Mexico Cancer Care Alliance
Recruiting --> Completed Recruiting --> Terminated; Terminated due to inadequate rate of accrual.
- Avastin (bevacizumab) / Roche
Enrollment change: Study of Revlimid With Doxil and Avastin for Patients With Platinum Resistant Ovarian Cancer (clinicaltrials.gov) - Jun 28, 2012
P1, N=1, Terminated, Sponsor: New Mexico Cancer Care Alliance
Recruiting --> Terminated; Terminated due to inadequate rate of accrual. N=48 --> 1
- Trial completion, Surgery: Surgery and Vaccine Therapy in Treating Patients With Early Cervical Cancer (clinicaltrials.gov) - Jun 28, 2012
P2, N=44, Completed, Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
N=48 --> 1 Active, not recruiting --> Completed
- ||||| estradiol sulfamate (PGL2001) / Gedeon Richter
New P2 trial: AMBER: PGL2001 Proof of Concept Study in Symptomatic Endometriosis (clinicaltrials.gov) - Jun 27, 2012
P2, N=132, Active, not recruiting, Sponsor: PregLem SA
- ||||| Rifalazil (benzoxazinorifamycin) / TrioBiotics
New P2 trial: Safety and Efficacy Study of Rifalazil for the Treatment of Chlamydia Trachomatis Infection in Women (clinicaltrials.gov) - Jun 27, 2012
P2, N=82, Completed, Sponsor: ActivBiotics Pharma, LLC
- Zokinvy (lonafarnib) / Eiger
Trial completion: Comparison of Paclitaxel/Carboplatin and Lonafarnib to Paclitaxel/Carboplatin for First-line Treatment of Ovarian Cancer (clinicaltrials.gov) - Jun 27, 2012
P2, N=105, Completed, Sponsor: AGO Study Group
Active, not recruiting --> Completed Active, not recruiting --> Completed